SARS Cov2 management

From Aaushi
Jump to navigation Jump to search

Management

prevention

Oxygen

Treatment overview (literature)

Remdesivir & baricitinib

Anticoagulation

ARDS

other therapeutics

Early outpatient management of Covid-19

oral medications for COVID-19

Monoclonal antibodies to COVID-19

= Convalescent plasma

outpatient glucocorticoids

outpatient pulse oximetry

nasal irrigation

Hospital Discharge & Follow-up

Quarantine

Unproven therapies

Therapies of no benefit

Investigational treatment

Medications, Comordities & COVID-19

Conservation with limited resources

Surgery

Prognosis

Institutional prevention

Public prevention

Pandemic management

Notes

Additional terms

References

  1. Paules CI, Marston HD, Fauci AS. Coronavirus Infections - More Than Just the Common Cold. JAMA. Published online Jan 23, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31971553 https://jamanetwork.com/journals/jama/fullarticle/2759815
  2. Centers for Disease Control & Prevention (CDC) CDC Health Alert Network January 8, 2020, 16 Outbreak of Pneumonia of Unknown Etiology (PUE) in Wuhan, China. https://emergency.cdc.gov/han/han00424.asp
  3. World Health Organization (WHO) Pneumonia of unknown cause - China Disease outbreak news. January 5, 2020 https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
  4. World Health Organization (WHO) Emergencies preparedness, response. Disease outbreak news : Update. Jan 12, 2020 Novel Coronavirus - China https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
  5. World Health Organization (WHO) News Release. Jan 13, 2020 WHO statement on novel coronavirus in Thailand. https://www.who.int/news-room/detail/13-01-2020-who-statement-on-novel-coronavirus-in-thailand
  6. Centers for Disease Control & Prevention (CDC) CDC Health Update. Jan 17, 2020 Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China https://emergency.cdc.gov/han/han00426.asp
  7. Walker M First Case of Coronavirus Lands in U.S.
    Novel virus detected in man from Washington state. MedPage Today. January 21, 2020 https://www.medpagetoday.com/infectiousdisease/publichealth/84458
    Johnson CK, Stobbe M US Gets First Case of Mysterious Chinese Coronavirus Medscape - Jan 21, 2020. https://www.medscape.com/viewarticle/924020
    Centers for Disease Control & Prevention (CDC) First Travel-related Case of 2019 Novel Coronavirus Detected in United States. CDC News Release. January 21, 2020 https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html
  8. Cadal C, Stanway D China's Wuhan shuts down transport as global alarm mounts over virus spread. Reuters. January 21, 2020 https://www.reuters.com/article/us-china-health-transmission/china-virus-deaths-rise-to-nine-heightening-global-alarm-idUSKBN1ZL07C
  9. Hua J, Cadal C China heads into Lunar New Year on shutdown as virus spreads to Europe. Reuters. January 22, 2020 https://www.reuters.com/article/us-china-health/china-puts-millions-on-lockdown-as-virus-toll-rises-to-18-and-who-weighs-response-idUSKBN1ZM087?
  10. World Health Organization (WHO) News Release. Jan 23, 2020 Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
  11. Young K As Novel Coronavirus Spreads, WHO Declines to Declare International Emergency Physician's First Watch, Jan 24, 2020 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  12. Zhu N, Zhang D, Wang W et al A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. January 24, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31978945 https://www.nejm.org/doi/full/10.1056/NEJMoa2001017
    Munster VJ, Koopmans M, van Doremalen N et al A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med. January 24, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31978293 https://www.nejm.org/doi/full/10.1056/NEJMp2000929
    Perlman S Another Decade, Another Coronavirus N Engl J Med. January 24, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31978944 https://www.nejm.org/doi/full/10.1056/NEJMe2001126
    Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Jan 24; PMID: https://www.ncbi.nlm.nih.gov/pubmed/31986264 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
    Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020 Jan 24; PMID: https://www.ncbi.nlm.nih.gov/pubmed/31986261 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/fulltext
  13. Centers for Disease Control & Prevention (CDC) CDC Situation Summary, Jan 26, 2020 2019 Novel Coronavirus (2019-nCoV), Wuhan, China https://www.cdc.gov/coronavirus/2019-ncov/summary.html
  14. Walker M 132 Dead as WHO Mulls Another Coronavirus Meeting - As cases pass 6,000, agency ponders whether to declare international health emergency. MedPage Today. January 29, 2020 https://www.medpagetoday.com/infectiousdisease/publichealth/84604
  15. Lu R, Zhao X, Li J et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020. Jan 30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32007145 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251-8/fulltext
  16. Chen N, Zhou M, Dong X et al Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. Jan 30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32007143 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
  17. World Health Organization (WHO), Jan 30,2020 WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov)
  18. Centers for Disease Control & Prevention (CDC) CDC Confirms Person-to-Person Spread of New Coronavirus in the United States. Press Release. Jan 30, 2020 https://www.cdc.gov/media/releases/2020/p0130-coronavirus-spread.html
    Rothe C, Schunk M, Sothmann P, Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med, Jan 30, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32003551 https://www.nejm.org/doi/full/10.1056/NEJMc2001468
  19. Brunk D HHS Declares Coronavirus Emergency,Orders Quarantine - Medscape - Jan 31, 2020. https://www.medscape.com/viewarticle/924640
    Walker M U.S. Declares Public Health Emergency for Coronavirus Dramatic steps taken for quarantining travelers, based on "unknown" nature of virus. MedPage Today. Jan 31, 2020 https://www.medpagetoday.com/infectiousdisease/publichealth/84662
  20. Young J, George S, Kottasova I Nearly 12,000 cases of the coronavirus worldwide. CNN. Feb 1, 20220 https://www.cnn.com/asia/live-news/coronavirus-outbreak-02-01-20-intl-hnk/index.html
  21. Hollingsworth J Coronavirus. CNN. Feb 2, 2020 https://www.cnn.com/2020/02/02/asia/wuhan-coronavirus-philippines-intl-hnk/index.html
  22. Center for Disease Control & Prevention (CDC) Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV). CDC Health Update. February 1, 2020 https://emergency.cdc.gov/han/han00427.asp
  23. Holshue ML, DeBolt C, Lindquist S et al First Case of 2019 Novel Coronavirus in the United States. N Emgl J Med. Jam 31, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32004427 https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
  24. Center for Disease Control & Prevention (CDC) CDC Confirms Seventh Case of 2019 Novel Coronavirus Media Statement. Jan 31. 2020 https://www.cdc.gov/media/releases/2020/s0131-seventh-case-coronavirus.html
  25. Wu JT, Leung K, Leung GM Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. Jan 31, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32014114 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30260-9/fulltext
  26. Center for Disease Control & Prevention (CDC) 2019 Novel Coronavirus (2019-nCoV) in the U.S. Situation Simmary. Feb 3, 2020 https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
  27. Center for Disease Control & Prevention (CDC) 2019 Novel Coronavirus, Wuhan, China. https://www.cdc.gov/coronavirus/2019-ncov/index.html
    Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential 2019 Novel Coronavirus (2019-nCoV.) Exposure in Travel-associated or Community Settings. https://www.cdc.gov/coronavirus/2019-ncov/php/risk-assessment.html
  28. FDA Press Announcement Feb 4, 2020 FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic. Critical Milestone Reached in Response to this Outbreak. https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
  29. Brink D Remdesivir Under Study as Treatment for Novel Coronavirus. Medscape - Feb 07, 2020. https://www.medscape.com/viewarticle/924964
  30. Walker M Track the Coronavirus Outbreak on Johns Hopkins Live Dashboard.
    Realtime infection and death data from five sources. MedPage Today. February 04, 2020 https://www.medpagetoday.com/infectiousdisease/publichealth/84698
    Johns Hopkins Live Dashboard. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
  31. Wang D, Hu B, Hu C et al Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus - Infected Pneumonia in Wuhan, China. JAMA. Published online Feb 7, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32031570 https://jamanetwork.com/journals/jama/fullarticle/2761044
  32. Gorbalenya AE Severe acute respiratory syndrome-related coronavirus - The species and its viruses, a statement of the Coronavirus Study Group. biorxiv. Cold Spring Harbor Laboratory, Feb 11, 2029 https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1
    Centers for Disease Control & Prevention (CDC) CDC Confirms 13th Case of 2019 Novel Coronavirus Media Statement. February 10, 2020 https://www.cdc.gov/media/releases/2020/s0210-coronavirus-new-us-case.html
    World Health Organization (WHO) WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
    UC San Diego Health. Feb 11, 2019 Coronavirus (COVID-19) Updates https://health.ucsd.edu/news/Pages/Coronavirus-update.aspx
  33. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W et al Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. Feb 12, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32151335 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30360-3/fulltext
  34. World Health Organization (WHO) Coronavirus disease 2019 (COVID-19)Situation Report - 28. Feb 17, 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf
  35. Gilbert M, Pullano G, Pinotti F et al Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. Feb 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32087820 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30411-6/fulltext
  36. Centers for Disease Control & Prevention (CDC) Coronavirus Disease 2019 (COVID-19) in the U.S. Updated Feb 24, 2020 https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
  37. Young K, Fairchild DG, Di Francesco L CDC Anticipates Community Spread of COVID-19 in U.S. Physician's First Watch, Feb 26, 2020 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  38. Livingston E, Bucher K, Rekito A. JAMA Infographic: Coronavirus Disease 2019 and Influenza. JAMA. Published online February 26, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32101254 https://jamanetwork.com/journals/jama/fullarticle/2762386
  39. Centers for Disease Control & Prevention (CDC) 2019 Novel Coronavirus, Wuhan, China Information for Laboratories https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html
    Lan L, Xu D, Ye G et al Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. Published online February 27, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32105304 https://jamanetwork.com/journals/jama/fullarticle/2762452
  40. Gever J Looks Like Coronavirus Community Spread Is Here - Three new COVID-19 cases with unknown origin, CDC reports. MedPage Today. February 29, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/85161
  41. Beasley D How long can coronavirus survive on surfaces? Reuters via MSN Feb 28. 2020 https://www.msn.com/en-us/health/wellness/how-long-can-coronavirus-survive-on-surfaces/ar-BB10xkvI
  42. 42.0 42.1 Walker M FAQs About COVID-19 - Answers to frequently asked questions based on the latest medical research and public health data. MedPage Today. February 29, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/85165
    van Doremalen N, Bushmaker T, Morris DH et al Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. March 17, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32182409 https://www.nejm.org/doi/full/10.1056/NEJMc2004973
  43. Orciari Herman A, Fairchild DG, Hefner E COVID-19: CDC Reports First Possible Case of Community Spread in U.S. CDC Anticipates Community Spread of COVID-19 in U.S. Physician's First Watch, March 2, 2020
    Young K, Fairchild DG, Di Francesco L COVID-19: Secondary Attack Rate / Equivocal Lopinavir-Ritonavir Results Physician's First Watch, March 3, 2020 David G. Fairchild DG, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
  44. Burke RM, Midgley CM, Dratch A, et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep. ePub: 3 March 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32134909 https://www.cdc.gov/mmwr/volumes/69/wr/mm6909e1.htm
  45. Young BE, Ong SWX, Kalimuddin S et al Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. Published online March 3, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32125362 https://jamanetwork.com/journals/jama/fullarticle/2762688
  46. Walker M COVID-19 Update: First Calif. Death; Another Cruise Ship? MedPage Today March 5, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/85245
  47. 47.0 47.1 Hoffmann M, Kleine-Weber H, Schroeder S SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Mar 4. pii: S0092-8674(20)30229-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32142651
  48. 48.0 48.1 Goodman B. The Power of Hand-Washing to Prevent Coronavirus. Medscape - Mar 06, 2020. https://www.medscape.com/viewarticle/926373
  49. Sharfstein JM, Becker SJ, Mello MM. Diagnostic Testing for the Novel Coronavirus. JAMA. Published online March 9, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32150622 https://jamanetwork.com/journals/jama/fullarticle/2762951
  50. Zhou F, Yu T, Du R et al Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet March 9,2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32171076 https://www.thelancet.com/pb-assets/Lancet/pdfs/S014067362305663.pdf
  51. Orciari Herman A COVID-19 Can Look Like the Common Cold, Researchers Say. NEJM Journal Watch. March 10, 2020 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
  52. 52.0 52.1 Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020. Apr 21;323(15):1499-1500. March 11 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32159735 https://jamanetwork.com/journals/jama/fullarticle/2762996
  53. 53.0 53.1 Hollander JE, Carr BG Perspective: Virtually Perfect? Telemedicine for Covid-19 N Eng L Med. March 11, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32160451 https://www.nejm.org/doi/full/10.1056/NEJMp2003539
  54. Wang M, Cao R, Zhang L et al Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32020029 Free PMC Article
  55. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents J Hosp Infect. 2020 Mar;104(3):246-251. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32035997
  56. World Health Organization (WHO) Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim Guidance. March 13, 2020 https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
  57. 57.0 57.1 Wu C, Chen X, Cai Y et al Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. Published online March 13, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32167524 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
    Jeronimo CMP et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): A randomised, double-blind, Phase IIb, placebo- controlled trial. Clin Infect Dis 2020 Aug 12 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32785710 PMCID: PMC7454320 Free PMC article https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1177/5891816
  58. Li R, Pei S, Chen B et al Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 16 Mar 2020: PMID: https://www.ncbi.nlm.nih.gov/pubmed/32179701 https://science.sciencemag.org/content/early/2020/03/13/science.abb3221
  59. 59.0 59.1 Ng K, Poon BH, Puar THK et al COVID-19 and the Risk to Health Care Workers: A Case Report. Ann Intern Med. 2020. March 16 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32176257 https://annals.org/aim/fullarticle/2763329/covid-19-risk-health-care-workers-case-report
  60. 60.0 60.1 60.2 60.3 60.4 Statement from the American Heart Association, the Heart Failure Society of America and the American College of Cardiology. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. News Release. March 17, 2020 https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician
    HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. Am Coll Cardiol. March 17, 2020 https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19
    Famg L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020. March 11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32171062 https://www.thelancet.com/action/showPdf
    Vaduganathan M, Vardeny O, Michel T et al Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. March 30, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32227760 https://www.nejm.org/doi/full/10.1056/NEJMsr2005760
    Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What is the evidence? JAMA 2020 Mar 24; PMID: https://www.ncbi.nlm.nih.gov/pubmed/32208485 https://jamanetwork.com/journals/jama/fullarticle/2763803
    Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res 2020 Mar 4 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32129518 https://onlinelibrary.wiley.com/doi/full/10.1002/ddr.21656
    Muller BS et al. Regret among primary care physicians: A survey of diagnostic decisions. BMC Fam Pract 2020 Mar 17; 21:53 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32183738 Free PMC Article https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-020-01125-w
    Zhang P, Zhu L, Cai J et al Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. April 17, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32302265 https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.120.317134
    Li J, Wang X, Chen J et al Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. JAMA Cardiol. Published online April 23, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32324209 https://jamanetwork.com/journals/jamacardiology/fullarticle/2765049
    Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. May 1, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32356627 https://www.nejm.org/doi/full/10.1056/NEJMoa2006923
    Reynolds HR, Adhikari S, Pulgarin C et al Renin-Angiotensin-Aldosterone System Blockers and Risk of Covid-19. N Engl J Med. May 1, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32356628 https://www.nejm.org/doi/full/10.1056/NEJMoa2008975
    Jarcho JA, Ingelfinger JR, Hamel MB et al Inhibitors of the Renin-Angiotensin-Aldosterone System and COVID-19. N Engl J Med. May 1, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32356625 https://www.nejm.org/doi/full/10.1056/NEJMe2012924?query=RP
    de Abajo FJ et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: A case-population study. Lancet. 2020 May 14:S0140-6736(20)31030-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32416785 https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31030-8.pdf
    Fosbol EL, Butt JM, Ostergaard L et al Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. Published online June 19, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32558877 https://jamanetwork.com/journals/jama/fullarticle/2767669
    Curfman G Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19. JAMA. Published online June 19, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32558905 https://jamanetwork.com/journals/jama/fullarticle/2767668
    Lopes RD, Macedo AVS, de Barros E Silva PGM et al Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19. A Randomized Clinical Trial. JAMA. 2021;325(3):254-264. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33464336 https://jamanetwork.com/journals/jama/fullarticle/2775280
  61. Yao X,Ye F Zhang M et al I n Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases. March 2020 https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa237/5801998
    Lecrubier A COVID-19: Could Hydroxychloroquine Really Be the Answer? Medscape. March 18, 2020 https://www.medscape.com/viewarticle/927033
    Chen Z, Hu J, Zhang Z et al Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. Unreviewed manuscript. April 1, 2020 https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v2.full.pdf
  62. Cao B, Wang Y, Wen D et al A Trial of Lopinavir - Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. March 18, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32187464 Free PMC article https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
  63. Weixel N FDA authorizes first rapid, 'point of care' coronavirus test. The Hill. March 21, 2020 https://www.msn.com/en-us/health/health-news/fda-authorizes-first-rapid-point-of-care-coronavirus-test/ar-BB11vTxm
    FDA News Release. March 21, 2020 Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic
  64. 64.0 64.1 FDA Safety Alert. March 19, 2020 FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19 https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19
  65. 65.0 65.1 FDA Letter to Health Care Providers. March 2020 Medical Glove Conservation Strategies: Letter to Health Care Providers https://www.fda.gov/medical-devices/letters-health-care-providers/medical-glove-conservation-strategies-letter-health-care-providers
  66. 66.0 66.1 FDA Letter to Health Care Providers. March 2020 Ventilator Supply Mitigation Strategies: Letter to Health Care Providers. https://www.fda.gov/medical-devices/letters-health-care-providers/ventilator-supply-mitigation-strategies-letter-health-care-providers
  67. 67.0 67.1 Arentz M, Yim E, Klaff L et al Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Published online March 19, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32191259 https://jamanetwork.com/journals/jama/fullarticle/2763485
  68. Hopkins C, Kumar N Loss of sense of smell as marker of COVID-19 infection. ENT UK. March 2020 https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf
    NEJM JWatch Editors The Latest in COVID-19 News: Week Ending March 28 Physician's First Watch, March 28, 2020 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Spinato G, Fabbris C, Polesel J et al Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. Published online April 22, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32320008 https://jamanetwork.com/journals/jama/fullarticle/2765183
    Carroll L COVID-19 Associated Loss of Smell, Taste Mostly Resolves Within Weeks Medscape - Jul 02, 2020.. https://www.medscape.com/viewarticle/933347
    Boscolo-Rizzo P, Borsetto D, Fabbris C et al Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. Published online July 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32614442 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2767781
    Levy JM Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19 - The Coming Deluge. JAMA Otolaryngol Head Neck Surg. Published online July 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32614399 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2767779
  69. JAMA Morning Rounds. March 25, 2020 FDA to allow physicians to use plasma donated by coronavirus survivors to treat critically ill patients.
    NBC News. March 24, 2020 FDA will allow doctors to treat critically ill coronavirus patients with blood from survivors https://www.n bcnews.com/news/us-news/fda-will-allow-doctors-treat-critically-ill-coronavirus-patients-blood-n1167831
  70. 70.0 70.1 Pan C, Chen L, Lu C et al Lung Recruitability in SARS-CoV-2 Associated Acute Respiratory Distress Syndrome: A Single-center, Observational Study. Am J Respir Crit Care Med. 2020 Mar 23. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32200645 https://www.atsjournals.org/doi/pdf/10.1164/rccm.202003-0527LE
  71. Gautret P, Lagier JC, Parola P Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32205204 https://drive.google.com/file/d/186Bel9RqfsmEx55FDum4xY_IlWSHnGbj/view
  72. 72.0 72.1 Shi S, Qin M, Shen B et al Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. Published online March 25, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32211816 https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524
    Yang C, Jin Z An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic - COVID-19 and Cardiovascular Diseases. JAMA Cardiol. Published online March 25, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32211809 https://jamanetwork.com/journals/jamacardiology/fullarticle/2763525
  73. Song F, Shi N, Shan F et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020 Apr; 295:210 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32027573 https://pubs.rsna.org/doi/10.1148/radiol.2020200274
  74. Shen C, Wang Z, Zhao F et al Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma JAMA. 2020;323(16):1582-1589. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32219428 https://jamanetwork.com/journals/jama/fullarticle/2763983
    Roback JD, Guarner J. Convalescent Plasma to Treat COVID-19. Possibilities and Challenges. JAMA. Published online March 27, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32219429 https://jamanetwork.com/journals/jama/fullarticle/2763982
    FDA - Investigational New Drug (IND). March 24, 2020 Investigational COVID-19 Convalescent Plasma - Emergency INDs
    FDA News Release Coronavirus (COVID-19) Update: Daily Roundup April 3, 2020 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-3-2020 Duab K, Liu B, Li C et al Effectiveness of convalescent plasma therapy in severe COVID-19 patients. PNAS first published April 6, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32253318 https://www.pnas.org/content/early/2020/04/02/2004168117
    U.S. Department of Health and Human Services. Food and Drug Administration. Center for Biologics Evaluation and Research. April 2020 Investigational COVID-19 Convalescent Plasma Guidance for Industry. https://www.fda.gov/media/136798/download
    Duan K, Liu B, Li C et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A 2020 Apr 6; PMID: https://www.ncbi.nlm.nih.gov/pubmed/32253318 https://www.pnas.org/content/early/2020/04/02/2004168117
    FDA Statement. April 16, 2020 Coronavirus (COVID-19) Update: FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-encourages-recovered-patients-donate-plasma-development-blood
    Weiland N, LaFraniere S, Fink S F.D.A's Emergency Approval of Blood Plasma Is Now on Hold. New York Times. August 19, 2020 https://www.nytimes.com/2020/08/19/us/politics/blood-plasma-covid-19.html
    FDA. August 23, 2020 Recommendations for Investigational COVID-19 Convalescent Plasma https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds
    Joyner MJ, Senefeld JW, Klassen SA Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. medRxiv. August 12, 2020 https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1
    National Institutes of Health. Sept 1, 2020 The COVID-19 Treatment Guidelines Panel's Statement on the Emergency Use Authorization of Convalescent Plasma for the Treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/statement-on-convalescent-plasma-eua/
    FDA Letter to Nikki Bratcher-Bowman, Acting Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services. from RADM Denise M. Hinton, Feb 4, 2021 https://www.fda.gov/media/141477/download
  75. 75.0 75.1 Stone W Using UV Light to Fight COVID-19 Spread Medscape - Jul 23, 2020. https://www.medscape.com/viewarticle/934446103) Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. ePub: 27 March 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32240128 https://www.cdc.gov/mmwr/volumes/69/wr/mm6913e1.htm
  76. 76.0 76.1 Walker M Study: IL-7 May Help Severe COVID-19 Patients - Small case series in Belgium finds improvement in lymphocyte levels with immunotherapy. MedPage Today July 22, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/87695
    Laterre PF, Francois B, Collienne C et al Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020;3(7):e2016485 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32697322 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768536
  77. 77.0 77.1 Escobar LE, Molina-Cruz A, Barillas-Mury C BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci U S A. 2020 Jul 9:2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32647056 https://www.pnas.org/content/early/2020/07/07/2008410117
  78. 78.0 78.1 Kincaid E COVID-19 Daily: Universal Mask Usage, Death Projection. Medscape - Apr 01, 2020. https://www.medscape.com/viewarticle/927974
    Firth S It's Official: CDC Recommends Public Wear Face Masks - Stresses use of cloth coverings, not medical grade, for ordinary people. https://www.medpagetoday.com/infectiousdisease/covid19/85800
    Centers for Disease Control & Prevention (CDC) Recommendation Regarding the Use of Cloth Face Coverings, Especially in Areas of Significant Community-Based Transmission. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html
    Centers for Disease Control & Prevention (CDC) Use of Cloth Face Coverings to Help Slow the Spread of COVID-19 https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html
    Greenhalgh T, Schmid MB, Czypionka T et al Face masks for the public during the covid-19 crisis BMJ 2020;369:m1435 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32273267 https://www.bmj.com/content/369/bmj.m1435
  79. 79.0 79.1 Klompas M, Morris CA, Sinclair J et al Universal Masking in Hospitals in the Covid-19 Era. N Engl J Med. April 1, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32237672 https://www.nejm.org/doi/full/10.1056/NEJMp2006372
  80. 80.0 80.1 80.2 Fiore K COVID Clinical Observations: Intubating Colleagues, Proning to Prevent the Vent - Physicians share clinical information on Twitter to help others prepare for when the COVID wave hits their hospitals. MedPage Today. April 2, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/85767
  81. 81.0 81.1 81.2 Terry K Hard Truths From Infectious Disease Specialists Medscape - Apr 04, 2020. https://www.medscape.com/viewarticle/928146
  82. 82.0 82.1 Grein J, Ohmagari N, Shin D et al Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. April 10, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32275812 https://www.nejm.org/doi/full/10.1056/NEJMoa2007016
    National Institutes of Health NIH clinical trial of remdesivir to treat COVID-19 begins News Release. Feb 25, 2020 https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins
    Beigel JH, Tomashek KM, Dodd LE et al Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. May 22, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32445440 https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
  83. 83.0 83.1 Thachil J, Tang N, Gando S et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19 J Thromb Haemost 2020 Mar 25; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/32338827 https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14810
  84. 84.0 84.1 Kincaid E COVID-19 Daily: Noninvasive Ventilation Support, 'Terrified' in ICU Medscape - Apr 07, 2020 https://www.medscape.com/viewarticle/928328
  85. 85.0 85.1 85.2 85.3 85.4 85.5 Caly L, Druce JD, Catton MG et al The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. Published online April 3, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32251768 Free PMC Article https://www.sciencedirect.com/science/article/pii/S0166354220302011
    FDA Safety information. April 10, 2020 Ivermectin Intended for Animals: Letter to Stakeholders - Do Not Use in Humans as a Treatment for COVID-19. https://www.fda.gov/safety/medical-product-safety-information/ivermectin-intended-animals-letter-stakeholders-do-not-use-humans-treatment-covid-19
    Hlavinka E Ivermectin for COVID-19: Worth a Shot? Evidence base limited, including one withdrawn study with Surgisphere data MedPage Today August 27, 2020 https://www.medpagetoday.com/special-reports/exclusives/88310
    Frontline COVID-19 Critical Care Alliance (FLCCC) Prophylaxis & Treatment Protocols for COVID-19 https://covid19criticalcare.com/
    Kory P et al Clinical and Scientific Rationalefor the "MATH+" Hospital Treatment Protocol for COVID-19 Journal of Intensive Care. Dec 2020 https://covid19criticalcare.com/wp-content/uploads/2020/12/MATH-plus-Rationale-Journal-of-Intensive-Care-Medicine-Dec2020.pdf
    Sax PE Ivermectin for COVID-19 - Breakthrough Treatment or Hydroxychloroquine Redux? N Eng J Med Journal Watch HIV and ID Observations. Jan 4, 2021 https://blogs.jwatch.org/hiv-id-observations/index.php/ivermectin-for-covid-19-breakthrough-treatment-or-hydroxychloroquine-redux/2021/01/04/
    Frellick M Controversy Flares Over Ivermectin for COVID-19. Medscape. Jan 20, 2021 https://www.medscape.com/viewarticle/944440
    COVID-19 Treatment Guidelines Panel. The COVID-19 Treatment Guidelines Panel's statement on the use of ivermectin for the treatment of COVID-19. 2021 Jan 14 https://www.covid19treatmentguidelines.nih.gov/statement-on-ivermectin
    Lopez-Medina E, Lopez P, Hurtado IC et al Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19. A Randomized Clinical Trial, JAMA. Published online March 4, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33662102 https://jamanetwork.com/journals/jama/fullarticle/2777389
  86. 86.0 86.1 Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open. 2020;3(4):e205619 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32275319 Free Article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764293
  87. 87.0 87.1 Sanders JM, Monogue ML, Jodlowski TZ et al Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A Review. JAMA. Published online April 13, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32282022 https://jamanetwork.com/journals/jama/fullarticle/2764727
  88. 88.0 88.1 88.2 Leung NHL, Chu DKW, Shiu EYC et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020 Apr 2; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32371934 https://www.nature.com/articles/s41591-020-0843-2
  89. 89.0 89.1 Somers EC, Eschenauer GA, Troost JP Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clinical Infectious Diseases, ciaa954, Published: July 11, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32651997 https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa954/5870306
  90. 90.0 90.1 Ledford H How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. Nature, NEWS 09 April 2020 https://www.nature.com/articles/d41586-020-01056-7
    Xu X, Han M, Li T et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A 2020 Apr 29; PMID: https://www.ncbi.nlm.nih.gov/pubmed/32350134 https://www.pnas.org/content/early/2020/04/27/2005615117
  91. 91.0 91.1 Broyd N Nicky Broyd. Oxford COVID-19 Vaccine Trial 'Within Weeks': Q&A - Medscape - Apr 18, 2020 https://www.medscape.com/viewarticle/928941
  92. 92.0 92.1 92.2 92.3 92.4 NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Updated. April 21, 2020 https://covid19treatmentguidelines.nih.gov/
    Alhazzani W et al. Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020 Mar 27 https://journals.lww.com/ccmjournal/Abstract/9000/Surviving_Sepsis_Campaign__Guidelines_on_the.95707.aspx
    Wilson KC et al. COVID-19: Interim guidance on management pending empirical evidence; from an American Thoracic Society-led international task force. 2020 Apr 3 https://www.thoracic.org/covid/covid-19-guidance.pdf
    Bhimraj A et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. 2020 Apr 11 https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management
  93. 93.0 93.1 AMA Morging Rounds. July 14, 2020
    Sakoulas G, El Sahly H, Ellison RT III. Chloroquine and Hydroxychloroquine: Old Drugs in A New COVID-19 World. NEJM Journal Watch. April 24, 2020 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
    Guastalegname M, Vallone A Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? Clin Infect Dis. 2020 Mar 24. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32211771
    Yazdany J, Kim AHJ. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Ann Intern Med. 2020 Mar 31. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32232419 Free PMC Article https://annals.org/aim/fullarticle/2764199/use-hydroxychloroquine-chloroquine-during-covid-19-pandemic-what-every-clinician
    Damle B, Vourvahis M, Wang E et al Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19. Clin Pharmacol Ther. 2020 Apr 17.Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32302411
    Sinha N, Balayla G. Hydroxychloroquine and covid-19. Postgrad Med J. 2020 Apr 15. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32295814
    Alia E, Grant-Kels JM. Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence. J Am Acad Dermatol. 2020 Apr 10. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32283236 Free PMC Article
  94. 94.0 94.1 Jancin B COVID-19 Panel: Helmet CPAP, Pronation Key Tools for Some Patients. Medscape - Apr 23, 2020. https://www.medscape.com/viewarticle/929285
  95. 95.0 95.1 Borba MGS, Val FFA, Sampaio VS et al Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. A Randomized Clinical Trial. JAMA Netw Open. 2020;3(4.23):e208857 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32330277 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765270
    Fihn SD, Perencevich E, Bradley SM Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019. JAMA Netw Open. 2020;3(4.23):e209035 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32330276 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765269
  96. 96.0 96.1 96.2 Caputo N, Strayer RJ, Levitan R Early Self-Proning in Awake Non-intubated Patients in the Emergency Department: A single ED;s Experimen during the COVID-19 Pandemic. Academic Emergency Medicine. April 22 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32320506 https://onlinelibrary.wiley.com/doi/epdf/10.1111/acem.13994 Ghelichkhani P, Esmaeili M. Prone Position in Management of COVID-19 Patients; a Commentary. Arch Acad Emerg Med. 2020 Apr 11;8(1):e48. eCollection 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32309812 Free PMC Article
  97. 97.0 97.1 97.2 97.3 97.4 Phend C COVID-19: Anticoagulation Recommended Even After Discharge. Guidance from consensus group and others details on use across settings MedPage Today April 30, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/86230
    Bikdeli B, Madhavan MV, Jimenez D et al COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J Am Coll Cardiol 2020; April 17 online PMID: https://www.ncbi.nlm.nih.gov/pubmed/32311448 Free PMC Article https://www.sciencedirect.com/science/article/pii/S0735109720350087
    Paranjpe I, Fuster V, Lala A et al Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. Journal of the American College of Cardiology. May 2020 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/32387623 Free PMC Article <Internet> http://www.onlinejacc.org/content/early/2020/05/05/j.jacc.2020.05.001
    Phend C Full-Dose Clot Prophylaxis for COVID-19 Tied to Mortality - But small numbers and retrospective design leave the question open for RCTs. MedPage Today July 28, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/87792
    Motta JK, et al Clinical outcomes with the use of prophylactic versus therapeutic anticoagulation in COVID-19. medRxiv 2020 July Not indexed in PubMed https://www.medrxiv.org/content/medrxiv/early/2020/07/26/2020.07.20.20147769.full.pdf
    Piazza G, Morrow DA Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19. JAMA. Published online November 23, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33226423 https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23422
  98. Geleris J, Sun Y, Platt J et al Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. May 7, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32379955 https://www.nejm.org/doi/full/10.1056/NEJMoa2012410
  99. 99.0 99.1 Cavalli G, DeLuca G, Campochiara C et al Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study The Lancet Rheumatology. 2020 Jun;2(6):e325-e331. May 7, 2020 online PMID: https://www.ncbi.nlm.nih.gov/pubmed/32501454 Free PMC article https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext
  100. 100.0 100.1 100.2 Cohen E, Nigam M Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed. CNN Health. May 9, 2020. https://www.cnn.com/2020/05/09/health/famotidine-covid-19-correlation-study/index.html
    Freedberg DE, Conigliaro J, Sobieszczyk ME et al Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. medRxiv. May 8, 2020 Not indexed in PubMed https://www.medrxiv.org/content/10.1101/2020.05.01.20086694v1
    Freedberg DE, Conigliaro J, Wang TC et al Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology. 2020 May 22:S0016-5085(20)34706-5 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32446698 Free PMC article
    Walker M More Evidence Heartburn Drug May Help COVID-19 Patients - Another observational study adds fuel to the fire, but more research is needed. MedPage Today August 17, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/88119
    Mather JF, Seip RL, McKay RG et al Impact of famotidine use on clinical outcomes of hospitalized COVID-19 patients. Am J Gastroenterol; August 14, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32852338 https://journals.lww.com/ajg/Documents/AJG-20-2074_R1.pdf
    Swift D Common Heartburn Drug for COVID-19 Symptoms? In case series, non-hospitalized patients felt better within 1-2 days of starting famotidine MedPage Today. June 4, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/86893
  101. 101.0 101.1 101.2 101.3 MSN: AFP May 10, 2020 Tests Show UUV lamps could light the way in virus fight. Cites Dr David Brenner Columbia's Center for Radiological Research preliminary results subnitted to the journal Nature. https://www.msn.com/en-us/health/health-news/tests-show-uvc-lamps-could-light-the-way-in-virus-fight/ar-BB13QOpt?li=BBnb7Kz
  102. 102.0 102.1 Hung IF, Lung KC, Tso EY et al Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. May 8, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32401715 Free PMC Article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31042-4/fulltext
  103. 103.0 103.1 Hamiel U, Kozer E, Youngster I SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults. JAMA. Published online May 13, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32401274 https://jamanetwork.com/journals/jama/fullarticle/2766182
  104. Orciari Herman A, Sadoughi S, Sofair A In Nonintubated COVID-19 Patients, Tolerating the Prone Position May Be Associated with Better Outcomes Physician's First Watch, May 17, 2020 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Sartini C, TresoldicM, Scarpellini P et al Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit. JAMA. Published online May 15, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32412606 https://jamanetwork.com/journals/jama/fullarticle/2766291
    Elharrar X, Trigui Y, Dols AM et al Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure. JAMA. Published online May 15, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32412581 https://jamanetwork.com/journals/jama/fullarticle/2766292
    Telias I, Katira BH, Brochard L Is the Prone Position Helpful During Spontaneous Breathing in Patients With COVID-19? JAMA. Published online May 15, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32412579 https://jamanetwork.com/journals/jama/fullarticle/2766290
  105. 105.0 105.1 105.2 McCall B Vitamin D: A Low-Hanging Fruit in COVID-19? Medscape - May 17, 2020 https://www.medscape.com/viewarticle/930660
    Hastie CE, Mackay DF, Ho F et al Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020 May 7;14(4):561-565 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32413819
    Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020 May 12. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32398871 Free PMC Article
    Hribar CA, Cobbold PH, Church FC. Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease. Brain Sci. 2020 May 8;10(5). Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32397275 Free Article
    McNamara D Low Vitamin D Linked to Increased COVID-19 Risk. Medscape - Jul 29, 2020. https://www.medscape.com/viewarticle/934835
    Merzon E, Tworowski D, Gorohovski A et al Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. July 23, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32700398 https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.15495
    Meltzer DO, Best TJ, Zhang H et al Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2020;3(9):e2019722. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32880651 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770157
    Maghbooli Z, Sahraian MA, Ebrahimi M et al Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLOS One Published: September 25, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32976513 PMCID: PMC7518605 Free PMC article https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799
  106. 106.0 106.1 Ellis R First COVID-19 Vaccine Tested on Humans Shows Early Promise, Medscape - May 18, 2020 https://www.medscape.com/viewarticle/930714
  107. 107.0 107.1 Pei S, Kandula S, Shaman J Differential Effects ofIntervention Timing on COVID-19 Spread in the United States. medRxiv. May 20, 2020. https://www.medrxiv.org/content/10.1101/2020.05.15.20103655v1.full.pdf
  108. 108.0 108.1 Mehra MR, Desai SS, Ruschitzka F, Patel AN Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. May 22, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32450107 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext * authors associated with Surgisphere implicated in false data *
    Cavalcanti AB, Zampieri FG, Rosa RG et al Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. July 23, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32706953 https://www.nejm.org/doi/full/10.1056/NEJMoa2019014
    Skipper CP et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19: A randomized trial. Ann Intern Med 2020 Jul 16; PMID: https://www.ncbi.nlm.nih.gov/pubmed/32673060 Free PMC article. https://www.acpjournals.org/doi/10.7326/M20-4207
    Schluger NW. The saga of hydroxychloroquine and COVID-19: A cautionary tale. Ann Intern Med 2020 Jul 16; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32673059 Free PMC article https://www.acpjournals.org/doi/10.7326/M20-5041
  109. 109.0 109.1 Pinto D, Park YJ, Beltramello M et al Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. May 18, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32422645 https://www.nature.com/articles/s41586-020-2349-y
  110. 110.0 110.1 Reuters. May 25, 2020 Clinical trial of hydroxychloroquine in COVID-19 patients paused-WHO. https://www.msn.com/en-us/news/world/clinical-trial-of-hydroxychloroquine-in-covid-19-patients-paused-who/ar-BB14zn1l?li=BBnb7Kz
  111. 111.0 111.1 Sen S, Karaca-Mandic P, Georgiou A Association of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States. JAMA. Published online May 27, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32459287 https://jamanetwork.com/journals/jama/fullarticle/2766673
  112. 112.0 112.1 Susman E HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows. MedPage Today May 28, 2020 https://www.medpagetoday.com/meetingcoverage/asco/86738
    Warner J, et al Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19). American Society of Clinical Oncology ASCO 2020; Abstract LBA110.
  113. 113.0 113.1 American Medical Association. April 29, 2020 DNR orders in a public health crisis https://www.ama-assn.org/delivering-care/ethics/dnr-orders-public-health-crisis
  114. 114.0 114.1 114.2 Chu DK, Aki EA, Duda S et al Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. June 1, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32497510 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31142-9/fulltext
  115. 115.0 115.1 Worsham CM, Banzett RB, Schwartzstein R Air Hunger and Psychological Trauma in Ventilated COVID-19 Patients: An Urgent Problem. Annals of the American Thoracic Society June 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32501114 https://www.thoracic.org/about/newsroom/press-releases/resources/air-hunger-and-psychological-trauma-in-covid1.pdf
  116. 116.0 116.1 Boulware DR, Pullen MF, Bangdiwala AS et al A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. June 3, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32492293 https://www.nejm.org/doi/full/10.1056/NEJMoa2016638
    Cohen MS Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence N Engl J Med. June 3, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32492298 https://www.nejm.org/doi/full/10.1056/NEJMe2020388
    Abella BS, Jolkovsky EL, Biney BT et al Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers. A Randomized Clinical Trial. JAMA Intern Med. Published online September 30, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33001138 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771265
  117. 117.0 117.1 Marcus JE, Frankel DN, Pawlak MT, et al. COVID-19 Monitoring and Response Among U.S. Air Force Basic Military Trainees - exas, March-April 2020. MMWR Morb Mortal Wkly Rep 2020;69:685-688 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32497031 Free article https://www.cdc.gov/mmwr/volumes/69/wr/mm6922e2.htm
  118. Li L, Zhang W, Hu Y et al Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19. A Randomized Clinical Trial. JAMA. Published online June 3, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32492084 https://jamanetwork.com/journals/jama/fullarticle/2766943
    Casadevall A, Joyner MJ, Pirofski LA A Randomized Trial of Convalescent Plasma for COVID-19 - Potentially Hopeful Signals. JAMA. Published online June 3, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32492105 https://jamanetwork.com/journals/jama/fullarticle/2766940
    Agarwal A, Mukherjee A, Kumar G et al Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ 2020;371:m3939 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33093056 https://www.bmj.com/content/371/bmj.m3939
    Pathak EB Convalescent plasma is ineffective for covid-19 BMJ 2020;371:m4072 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33093025 https://www.bmj.com/content/371/bmj.m4072
    Walker M Convalescent Plasma Flops for Severe COVID-19 - Randomized trial finds no benefit in clinical status or mortality vs placebo. MedPage Today November 24, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/89878
    Simonovich VA, Burgos Pratx LD, Scibona P et al A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. N Engl J Med. 2020. Nov 24. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33232588 https://www.nejm.org/doi/full/10.1056/NEJMoa2031304
  119. 119.0 119.1 119.2 Schunemann HJ et al. Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: A living systematic review of multiple streams of evidence. Ann Intern Med 2020 May 22; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32442035 Free PMC article. https://www.acpjournals.org/doi/10.7326/M20-2306
  120. 120.0 120.1 Vlessides M Can Mouthwash Douse the Spread of COVID-19? Medscape - Jun 12, 2020. https://www.medscape.com/viewarticle/932214
    Kirk-Bayley J et al The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers. SSRN. May 4, 2020 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3563092 https://ssrn.com/abstract=3563092 http://dx.doi.org/10.2139/ssrn.3563092
    Walker M Anti-COVID Mouthwash: Spit, Don't Swallow?
    Some reduction in viral load in infected patients, pilot study finds. MedPage Today February 4, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/91049
    Guenezan J, Garcia M, Strasters D et al Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. Published online February 4, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33538761 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2775984
  121. 121.0 121.1 Walker M HCQ No Longer Approved Even a Little for COVID-19 - Study after study showed no benefit, and now the FDA has had enough MedPage Today. June 15, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/87066
  122. 122.0 122.1 122.2 122.3 122.4 Walker M. Finally: Common Drug Improves COVID-19 Survival in Trial - "A ground-breaking development," according to preliminary data from an ongoing trial. MedPage Today June 16, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/87086
    Kelland K, Smout A Dexamethasone Hailed as 'Breakthrough' in COVID-19 Trial, Reduced Deaths. Medscape - Jun 16, 2020. https://www.medscape.com/viewarticle/932403
    RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY) Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. June 16, 2020 https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19 https://www.recoverytrial.net/files/recovery-protocol-v6-0-2020-05-14.pdf
    RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. N Engl J Med 2020 Jul 17; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/32678530 https://www.nejm.org/doi/10.1056/NEJMoa2021436
    Pasin L et al. Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2021 Feb; 35:57 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33298370 PMCID: PMC7698829 Free PMC article https://www.jcvaonline.com/article/S1053-0770(20)31292-1/fulltext
  123. 123.0 123.1 123.2 Thompson AE, Ranard BL, Wei Y et al Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure. JAMA Intern Med. Published online June 17, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32584946 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2767575
    Sarma A, Calfee CS Prone Positioning in Awake, Nonintubated Patients With COVID-19. Necessity Is the Mother of Invention. JAMA Intern Med. Published online June 17, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32584940 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2767574
  124. 124.0 124.1 De Luca G, Cavalli G, Campochiaro C et al GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatology. 2020 Aug;2(8):e465-e473 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32835256 PMCID: PMC7430344 Free PMC article https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30170-3/fulltext
    Freeman S Mavrilimumab May Aid Severe COVID-19 Recovery. Medscape - Jun 11, 2021. https://www.medscape.com/viewarticle/952941
  125. 125.0 125.1 Kewan T et al Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study. EClinicalMedicine from Lancet. Published:June 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32766537 Free PMC article. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30162-0/fulltext
  126. 126.0 126.1 126.2 Phend C Could Extended Anticoagulation Help After COVID-19? Trial analysis of post-discharge patients is suggestive for pandemic care. MedPage Today June 22, 2020 https://www.medpagetoday.com/cardiology/venousthrombosis/87200
    Spyropoulos AC, et al Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol Volume 75, Issue 25, June 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32586587 https://www.onlinejacc.org/content/75/25/3140.abstract
    Goldhaber SZ Thromboembolism Prophylaxis for Patients Discharged From the Hospital. Easier Said Than Done. J Am Coll Cardiol Volume 75, Issue 25, June 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32586588 https://www.onlinejacc.org/content/75/25/3148
    Ramacciotti E, Barile Agati L, Calderaro D et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): An open-label, multicentre, randomised, controlled trial. Lancet 2022 Jan 1; 399:50 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34921756 PMCID: PMC8673881 Free PMC article
  127. 127.0 127.1 Hsiang S, Allen D, Annan-Phan S et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature 2020 Jun 8; PMID: https://www.ncbi.nlm.nih.gov/pubmed/32512578 https://www.nature.com/articles/s41586-020-2404-8
  128. 128.0 128.1 Deftereos SG, Giannopoulos G, Vrachatis DA et al Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019. The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020;3(6):e2013136. June 24, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32579195 Free article. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767593
    Rabban ABi, Parikh RV, Rafique AM Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19) - An Old Drug With New Life? JAMA Netw Open. 2020;3(6):e2013556. June 24, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32579190 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767588
    Phend C Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home - But some find science-by-press-release troubling. MedPage Today January 26, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/90887
    Montreal Heart Institute Press Release Jan 22, 2021 https://app.cyberimpact.com/newsletter-view-online
    Wendling P ColCORONA: More Questions Than Answers for Colchicine in COVID-19 Medscape - Feb 08, 2021. https://www.medscape.com/viewarticle/945464
  129. 129.0 129.1 Guaraldi P, Meschiari M, Cozzi-Lepri A et al Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatology. 2020 Aug;2(8):e474-e484 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32835257 PMCID: PMC7314456 Free PMC article https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext
  130. 130.0 130.1 Louapre C, Collongues N, Stankoff B et al Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol. Published online June 26, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32589189 https://jamanetwork.com/journals/jamaneurology/fullarticle/2767776
  131. 131.0 131.1 131.2 Auger KA, Shah SS, Richardson T et al Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US. JAMA. Published online July 29, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32745200 https://jamanetwork.com/journals/jama/fullarticle/2769034
    Donohue JM, Miller E COVID-19 and School Closures JAMA. Published online July 29, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32745182 https://jamanetwork.com/journals/jama/fullarticle/2769033
  132. 132.0 132.1 132.2 Stauffer WM, Alpern JD, Walker PF COVID-19 and Dexamethasone. A Potential Strategy to Avoid Steroid- Related Strongyloides Hyperinfection. JAMA. Published online July 30, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32761166 https://jamanetwork.com/journals/jama/fullarticle/2769100
  133. 133.0 133.1 NIH News Release. Aug 6, 2020 NIH clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment begins. https://www.nih.gov/news-events/news-releases/nih-clinical-trial-testing-remdesivir-plus-interferon-beta-1a-covid-19-treatment-begins
  134. 134.0 134.1 Mustafa AK, Alexander PJ, Joshi DJ et al Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure. JAMA Surg. Published online August 11, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32780089 https://jamanetwork.com/journals/jamasurgery/fullarticle/2769429
    Barbaro RP et al. Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020 Oct 10; 396:107 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32987008 PMCID: PMC7518880 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32008-0/fulltext
  135. 135.0 135.1 Nadkarni GN, Lala A, Bagiella E et al Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study. J Am Coll Cardiol. Aug 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32860872 Free PMC article https://www.onlinejacc.org/content/early/2020/08/24/j.jacc.2020.08.041
    atell R, Chiasakul T, Bauer E, Zwicker JI. Pharmacologic thromboprophylaxis and thrombosis in hospitalized patients with COVID-19: A pooled analysis. Thromb Haemost 2021 Jan; 121:76. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33378787 Free PMC article.
    Al-Samkari H, Gupta S, Leaf RK et al. Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19. Ann Intern Med 2021 Jan 26; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33493012 Free PMC article.
  136. 136.0 136.1 Baral R, White M, Vassiliou VS Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients. Curr Atheroscler Rep 22, 61 (2020) PMID: https://www.ncbi.nlm.nih.gov/pubmed/32830286 PMCID: PMC7443394 Free PMC article https://link.springer.com/article/10.1007/s11883-020-00880-6
  137. Miller J WHO Cautious on COVID-19 Plasma as US Issues Emergency Authorization Medscape - Aug 24, 2020. https://www.medscape.com/viewarticle/936230
  138. Ault A. Convalescent Plasma Actions Spark Trial Recruitment Concerns. Medscape - Aug 26, 2020. https://www.medscape.com/viewarticle/936370
  139. 139.0 139.1 Kincaid E COVID-19 Update: Statins and Mortality, Value of Imperfect Tests. Medscape - Aug 28, 2020 https://www.medscape.com/viewarticle/936530
  140. 140.0 140.1 140.2 Dequin PF, Heming N, Meziani F et al Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. Sept 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32876689 https://jamanetwork.com/journals/jama/fullarticle/2770276
    The Writing Committee for the REMAP-CAP Investigators Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. Sept 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32876697 https://jamanetwork.com/journals/jama/fullarticle/2770278
  141. 141.0 141.1 141.2 Tomazini BM, Maia IS, Cavalcanti AB et al Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. Sept 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32876695 https://jamanetwork.com/journals/jama/fullarticle/2770277
  142. The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19A Meta-analysis. JAMA. Sept 2, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32876694 https://jamanetwork.com/journals/jama/article-abstract/2770279
    Prescott HC, Rice TW Corticosteroids in COVID-19 ARDSEvidence and Hope During the Pandemic. JAMA. Published online September 2, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32876693 https://jamanetwork.com/journals/jama/article-abstract/2770275
  143. 143.0 143.1 Zeng W, Wang X, Li J et al Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection. JAMA Ophthalmol. Published online September 16, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32936214 https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2770872
  144. 144.0 144.1 Frank S, Brown SM, Capriotti JA et al In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2. JAMA Otolaryngol Head Neck Surg. Published online September 17, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32940656 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2770785
    Farrell NF Cromwell CK, Schneider JS Benefits and Safety of Nasal Saline Irrigations in a Pandemic- Washing COVID-19 Away. JAMA Otolaryngol Head Neck Surg. 2020;146(9):787-788. July 23 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32722777 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2768627
    Radulesco T, Lechien JR, Michel J. Nasal Saline Irrigations in the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg. 2021;147(2):218 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33237269 https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2773583
    Farrell NF Cromwell CK, Schneider JS Nasal Saline Irrigations in the COVID-19 Pandemic - Reply JAMA Otolaryngol Head Neck Surg. 2021;147(2):219 Not indexed in PubMed https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2773585
    Parhar HS, Tasche K, Brody RM, et al Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head Neck. 2020 Jun;42(6):1268-1272. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32333619 Free PMC article. Review.
  145. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/ Accessed Oct 12, 2020
    NIH COVID-19 Treatment Guidelines What's New in the Guidelines Last Updated: October 9, 2020 https://www.covid19treatmentguidelines.nih.gov/whats-new/ Accessed Oct 12, 2020
  146. 146.0 146.1 van Haren FMP et al Nebulised Heparin as a Treatment for COVID-19. Crit Care. 2020 Jul 22;24(1):454. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32698853 Free PMC article.Review https://www.medscape.com/viewarticle/935702
  147. 147.0 147.1 Gupta S, Wang W, Hayek SS et al Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. Published online October 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33080002 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772185
    Salvarani C, Dolci G, Massari M et al Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia, A Randomized Clinical Trial. JAMA Intern Med. Published online October 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33080005 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772186
    Hermine O, Mariette X, Tharaux PL et al Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia, A Randomized Clinical Trial. JAMA Intern Med. Published online October 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33080017 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772187
    Parr JB Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia. JAMA Intern Med. Published online October 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33079980 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772184
  148. 148.0 148.1 Chen P, Nirula A, Heller B et al SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med 2020. Oct 28 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33113295 https://www.nejm.org/doi/full/10.1056/NEJMoa2029849
    FDA News Release. Nov 9, 2020 Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19
    NIH COVID-19 Treatment Guidelines. Nov 18, 2020. The COVID-19 Treatment Guidelines Panel's Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/statement-on-bamlanivimab-eua/
    ACTIV-3/TICO LY-CoV555 Study Group A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med 2020. Dec 22. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33356051 https://www.nejm.org/doi/full/10.1056/NEJMoa2033130
  149. 149.0 149.1 Diaz Y, Ramos-Suzarte M, Martin Y et al Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19 Gerontology. 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33105142 PMCID: PMC7649683 Free PMC article https://www.karger.com/Article/FullText/512210
  150. 150.0 150.1 150.2 Wilson EP Vitamin D for COVID? We've Been Burned Before. Medscape - Oct 28, 2020 https://www.medscape.com/viewarticle/939759
  151. 151.0 151.1 Brooks M PPI Use Tied to Increased Risk of Severe or Fatal COVID-19 Outcome in Meta-Analysis. Medscape - Nov 04, 2020. https://www.medscape.com/viewarticle/940390
    Li G-F et al. Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis. Gut 2020 Nov 10; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33172925 Free article https://gut.bmj.com/content/early/2020/11/10/gutjnl-2020-323366
    Kow CS, Hasan SS. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: A meta-analysis. J Intern Med 2020 Oct 20; PMID: https://www.ncbi.nlm.nih.gov/pubmed/33078881 https://onlinelibrary.wiley.com/doi/10.1111/joim.13183
    Lee SW, Ha EK, Yeniova AO, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: A nationwide cohort study with propensity score matching. Gut 2021 Jan; 70:76 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32732368 https://gut.bmj.com/content/70/1/76
  152. 152.0 152.1 AMA News. Nov 9, 2020 American Medical Association
    Hermine O, Mariette X, Tharaux PL et al Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia. A Randomized Clinical Trial. JAMA Intern Med. Published online October 20, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33080017 PMCID: PMC7577198 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772187
    Gupta A, Wang W, Hayek SS et al Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. Published online October 20, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33080002 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772185
    Stone JH, Frigault MJ, Serling-Boyd NJ et al Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 Oct 21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33085857 https://www.nejm.org/doi/full/10.1056/NEJMoa2028836
  153. 153.0 153.1 Crist C Melatonin Could Potentially Treat COVID-19, Study Says Medscape - Nov 11, 2020. https://www.medscape.com/viewarticle/940795
    EurekAlert, Cleveland Clinic researchers identify melatonin as possible COVID-19 treatment.
    Zhou Y, Hou Y, Shen J A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLOS Biology. 2020. Nov 6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33156843 Free article https://journals.plos.org/plosbiology/article
  154. 154.0 154.1 154.2 Lenze EJ, Mattar C, Zorumski CF et al Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial. JAMA. Published online November 12, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33180097 https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22760
    Seymour CW, Bauchner H, Golub RM. COVID-19 Infection - Preventing Clinical Deterioration. JAMA. Published online November 12, 2020. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33180115 https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21720
    Landhuis E Antidepressant Helps Prevent Hospitalization in COVID Patients: Study. Medscape August 27, 2021 https://www.medscape.com/viewarticle/957426
    Reis G, dos Santos Moreira Silva EA, Medeiros Silva DC et al Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial. medRxiv August 23, 2021 https://www.medrxiv.org/content/10.1101/2021.08.19.21262323v1
  155. 155.0 155.1 Monk PD, Marsden RJ, Tear VJ et al Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med 2020. Nov 12 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33189161 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30511-7/fulltext
  156. FDA News Release. Nov 21, 2020 Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19
  157. 157.0 157.1 FDA News Release. Vov 19, 2020 Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19
  158. 158.0 158.1 Cevik M, Tate M, Lloyd O et al SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The Lancet Microbe. 2020. Nov 19. Not indexed in PubMed https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30172-5/fulltext
    AMA Morning Report. Dec 3, 2020 American Medical Association
    Centers for Disease Control & Prevention (CDC). Dec 2, 2020 Options to Reduce Quarantine for Contacts of Persons with SAR.S-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing. https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-options-to-reduce-quarantine.html
  159. 159.0 159.1 159.2 Bharat A, Querrey M, Markov NS et al Lung transplantation for patients with severe COVID-19. Science Translational Medicine. 2020. Nov 30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33257409 https://stm.sciencemag.org/content/early/2020/11/25/scitranslmed.abe4282
    Walter K Lung Transplants for COVID-19 - The Option of Last Resort. JAMA. Published online June 17, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34137786 https://jamanetwork.com/journals/jama/fullarticle/2781358
    Kurihara C, Manerikar A, Querrey M et al Clinical Characteristics and Outcomes of Patients With COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant. JAMA. Published online January 27, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35085383 https://jamanetwork.com/journals/jama/fullarticle/2788640
  160. 160.0 160.1 FDA News Release. Nov 21, 2020 Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19
    NIH COVID-19 Treatment Guidelimes. Dec 2, 2020 The COVID-19 Treatment Guidelines Panel's Statement on the Emergency Use Authorization of the Casirivimab Plus Imdevimab Combination for the Treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/statement-on-casirivimab-plus-imdevimab-eua/
  161. 161.0 161.1 161.2 WHO Solidarity Trial Consortium Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med 2020. Dec 2 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33264556 https://www.nejm.org/doi/full/10.1056/NEJMoa2023184
  162. 162.0 162.1 Harrison P Extended Virus Shedding After COVID in Some Patients With Cancer Medscape - Dec 09, 2020. https://www.medscape.com/viewarticle/942290
  163. 163.0 163.1 163.2 Kalil AC, Patterson TF, Mehta AK et al Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med 2021; 384:795-807. March 4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33306283 PMCID: PMC7745180 Free PMC article https://www.nejm.org/doi/full/10.1056/NEJMoa2031994
  164. 164.0 164.1 Canadian Medical & Surgical Knowledge Translation Research Group Canadian pilot study suggests prescription icosapent ethyl (VASCEPA) might improve symptoms of COVID-19 and reduce inflammation. CISION News Release Dec 14, 2020 https://www.newswire.ca/news-releases/canadian-pilot-study-suggests-prescription-icosapent-ethyl-vascepa-r-might-improve-symptoms-of-covid-19-and-reduce-inflammation-843731620.html
  165. 165.0 165.1 Weinreich DM, Sivapalasingam S, Norton T et al REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med 2020. Dec 17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33332778 https://www.nejm.org/doi/full/10.1056/NEJMoa2035002
    Regeneron Pharmaceuticals. Jan 26, 2021 Regeneron Reports Positive Interim Data with REGEN-COV<TM> Antibody Cocktail used as Passive Vaccine to Prevent COVID-19. https://www.prnewswire.com/news-releases/regeneron-reports-positive-interim-data-with-regen-cov-antibody-cocktail-used-as-passive-vaccine-to-prevent-covid-19-301214619.html
  166. 166.0 166.1 Salama C, Han J, Yau L et al Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med 2020, Dec 17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33332779 https://www.nejm.org/doi/full/10.1056/NEJMoa2030340
  167. 167.0 167.1 Hughes S COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety Medscape - Dec 22, 2020. https://www.medscape.com/viewarticle/943085
  168. 168.0 168.1 Reuters Staff Vitamin D Fails to Help in Severe COVID-19. Medscape - Dec 28, 2020. https://www.medscape.com/viewarticle/943238
    Murai IH, Fernandes AL, Sales LP et al Effect of Vitamin D3 Supplementation vs Placebo on Hospital Length of Stay in Patients with Severe COVID-19: A Multicenter, Double-blind, Randomized Controlled Trial. medRxiv. Nov 17 2020 https://www.medrxiv.org/content/10.1101/2020.11.16.20232397v1
    Murai IH, Fernandes AL, Sales LP et al Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19. A Randomized Clinical Trial. JAMA. Published online February 17, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33595634 https://jamanetwork.com/journals/jama/fullarticle/2776738
    Leaf DE, Ginde AA Vitamin D3 to Treat COVID-19Different Disease, Same Answer JAMA. Published online February 17, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33595641 https://jamanetwork.com/journals/jama/fullarticle/2776736
  169. Libster R, Perez Marc G, Wappner D et al Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med 2021. Jan 6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33406353 https://www.nejm.org/doi/full/10.1056/NEJMoa2033700
    Joyner MJ, Carter RE, Senefeld JW et al Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med 2021 Jan 13. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33523609 PMCID: PMC7821984 Free PMC article https://www.nejm.org/doi/full/10.1056/NEJMoa2031893
  170. 170.0 170.1 The REMAP-CAP Investigators. Gordon AC, Mouncey PR, Al-Beidh F et al Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
    Preliminary report. medRxiv. Jan 7, 2021 Not indexed in PubMed https://www.medrxiv.org/content/10.1101/2021.01.07.21249390v1
    The REMAP-CAP Investigators. Gordon AC, Mouncey PR, Al-Beidh F et al Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med 2021. Feb 25 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33631065 https://www.nejm.org/doi/full/10.1056/NEJMoa2100433
    Rosas IO, Brau N, Waters M et al Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med 2021. Feb 25 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33631066 https://www.nejm.org/doi/full/10.1056/NEJMoa2028700
    Rubin EJ, Longo DL, Baden LR. Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup N Engl J Med 2021. Feb 25 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33631064 https://www.nejm.org/doi/full/10.1056/NEJMe2103108
  171. 171.0 171.1 Veiga VC Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ 2021;372:n84 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33472855 PMCID: PMC7815251 Free PMC article https://www.bmj.com/content/372/bmj.n84
  172. 172.0 172.1 Gottlieb RL, Nirula A, Chen P et al Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19A Randomized Clinical Trial. JAMA. Published online January 21, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33475701 https://jamanetwork.com/journals/jama/fullarticle/2775647
    Malani PN, Golub RM. Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19. JAMA. Published online January 21, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33475716 https://jamanetwork.com/journals/jama/fullarticle/2775645
  173. 173.0 173.1 Phend C Full-Dose Clot Prophylaxis Improves Outcomes in Moderate COVID-19 - Three major platform trials also show possible mortality benefit. MedPage Today January 22, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/90840
    Wendling P Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19 Medscape - Jan 22, 2021. https://www.medscape.com/viewarticle/944584
    NIH News Release. Jan 22, 2021 Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients. https://www.nih.gov/news-events/news-releases/full-dose-blood-thinners-decreased-need-life-support-improved-outcome-hospitalized-covid-19-patients
    Phend C Full-Dose Heparin Best for Moderate COVID-19 Regardless of D-dimer - Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials. MedPage Today January 29, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/90962
  174. 174.0 174.1 Phend C Trials Halt Full-Dose Clot Prophylaxis for Severe COVID-19 - Safety concerns cited in ACTIV-4, REMAP CAP, and ATTACC. MedPage Today December 20, 2020 https://www.medpagetoday.com/infectiousdisease/covid19/90351
  175. 175.0 175.1 Melville NA Metformin Treatment Again Linked to Fewer Deaths From COVID-19. Medscape - Jan 20, 2021. https://www.medscape.com/viewarticle/944386
  176. 176.0 176.1 World Health Organization (WHO) WHO recommends follow-up care, low-dose anticoagulants for COVID-19 patients. https://www.who.int/news-room/feature-stories/detail/who-recommends-follow-up-care-low-dose-anticoagulants-for-covid-19-patients
  177. Regeneron Pharmaceuticals. Jan 26, 2021 Regeneron Reports Positive Interim Data with REGEN-COV<TM> Antibody Cocktail used as Passive Vaccine to Prevent COVID-19. https://www.prnewswire.com/news-releases/regeneron-reports-positive-interim-data-with-regen-cov-antibody-cocktail-used-as-passive-vaccine-to-prevent-covid-19-301214619.html
  178. 178.0 178.1 COVID-19 Treatment Guidelines. Last Updated: February 3, 2021 The COVID-19 Treatment Guidelines Panel's Statement on the Use of Tocilizumab (and Other Interleukin-6 Inhibitors) for the Treatment of COVID-19. https://www.covid19treatmentguidelines.nih.gov/statement-on-tocilizumab/
  179. 179.0 179.1 179.2 Qaseem A, Yost J Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2) Ann Intern Med 2021. Feb 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33560862 https://www.acpjournals.org/doi/10.7326/M20-8101
  180. 180.0 180.1 Alexander W Peginterferon Lambda May Prevent Clinical Deterioration, Shorten Viral Shedding Medscape - Feb 10, 2021. https://www.medscape.com/viewarticle/945617
    Field JJ, Kandel C, Biondi MJ et al Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med. 2021 February 05 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33556319 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext
  181. 181.0 181.1 Thomas S, Patel D, Bittel B et al Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection. The COVID A to Z Randomized Clinical Trial. JAMA Netw Open. 2021;4(2):e210369. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33576820 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776305
  182. 182.0 182.1 182.2 182.3 Wendling P RECOVERY Trial of COVID Treatments Stops Colchicine Arm. Medscape - Mar 05, 2021 https://www.medscape.com/viewarticle/946978
  183. 183.0 183.1 Centers for Disease Control & Prevention (CDC) Interim Guidance on Duration of Isolation and Precautions for Adults with COVID-19. Summary of Recent Changes. Feb 13, 2021 https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html
  184. Centers for Disease Control & Prevention (CDC) Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Summary of Recent Changes. Feb 16, 2021 https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
  185. Bhimraj A, Morgan RL, Shumaker AH et al Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.0.0.pdf
  186. 186.0 186.1 Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: Cohort study. BMJ 2021 Feb 11; 372:n311. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33574135 PMCID: PMC7876672 Free PMC article https://www.bmj.com/content/372/bmj.n311
  187. 187.0 187.1 Chow JH, Khanna AK, Kethireddy S et al Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019. Anesthesia & Analgesia: April 2021. Volume 132 - Issue 4 - p 930-941 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33093359 https://journals.lww.com/anesthesia-analgesia/Fulltext/2021/04000/Aspirin_Use_Is_Associated_With_Decreased.2.aspx
  188. 188.0 188.1 INSPIRATION Investigators Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit. The INSPIRATION Randomized Clinical Trial. JAMA. Published online March 18, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33734299 https://jamanetwork.com/journals/jama/fullarticle/2777829
    Al-Samkari H Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19. JAMA. Published online March 18, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33734290 https://jamanetwork.com/journals/jama/fullarticle/2777828
  189. 189.0 189.1 Basen R, D'Ambrosio A. COVID-19 Treatments: What's In, What's Out - A look at which treatments are effective - and which aren't https://www.medpagetoday.com/special-reports/exclusives/91680
  190. 190.0 190.1 Grieco DL, Menga LS, Cesarano M et al Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure. The HENIVOT Randomized Clinical Trial. JAMA. Published online March 25, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33764378 https://jamanetwork.com/journals/jama/fullarticle/2778088
    Munshi L, Hall JB Respiratory Support During the COVID-19 Pandemic. Is It Time to Consider Using a Helmet? JAMA. Published online March 25, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33764370 https://jamanetwork.com/journals/jama/fullarticle/2778089
  191. 191.0 191.1 Reuters Staff WHO Joins Europe, Merck in Recommending Against Ivermectin for COVID-19. Medscape - Mar 31, 2021 https://www.medscape.com/viewarticle/948471
  192. 192.0 192.1 Banerjee J, Canamar CP, Voyageur C et al Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen. JAMA Netw Open. 2021;4(4):e213990. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33792728 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2778078
  193. 193.0 193.1 Roubinian NH et al. Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in northern California. JAMA Intern Med 2021 Apr 5; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33818615 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2778371
  194. 194.0 194.1 194.2 Russell P Corticosteroid Budesonide 'Shortens COVID-19 Recovery Time' Medscape - Apr 12, 2021. https://www.medscape.com/viewarticle/949099
    Gever J Inhaled Steroid for Early COVID-19 Passes Another Test. New analysis demonstrates speedier recovery for patients treated at home. MedPage Today April 12, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/92050
    Yu LM, Bafadhel M, Dorward J et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet 2021 Aug 10; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34388395 PMCID: PMC8354567 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01744-X/fulltext
  195. 195.0 195.1 195.2 195.3 Hughes S Therapeutic Rivaroxaban Dose: Risk Outweighs Benefit in Stable COVID. Medscape - May 19, 2021. https://www.medscape.com/viewarticle/951475
  196. 196.0 196.1 Ranjbar K, Moghadami M, Mirahmadizadeh A et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: A triple-blinded randomized controlled trial. BMC Infect Dis 2021 Apr 10; 21:337. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33838657 PMCID: PMC8035859 Free PMC article https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06045-3
  197. 197.0 197.1 Walker M Another JAK Inhibitor Shows Mortality Benefit in COVID-19. Tofacitinib cut incidence of severe outcomes in a population where most received steroids. MedPage Today June 16, 2021 https://www.medpagetoday.com/infectiousdisease/covid19/93148
    Guimaraes PO, Quirk D, Furtado RH et al Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. New Engl J Med 2021. June 16 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34133856 https://www.nejm.org/doi/full/10.1056/NEJMoa2101643
  198. 198.0 198.1 Lopes RD et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): An open-label, multicentre, randomised, controlled trial. Lancet 2021 Jun 12; 397:2253 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34097856 PMCID: PMC8177770 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01203-4/fulltext
  199. 199.0 199.1 Pal R, Banerjee M, Bhadada SK et al. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest 2021. June 24 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34165766 PMCID: PMC8223190 Free PMC article https://link.springer.com/article/10.1007/s40618-021-01614-4
  200. 200.0 200.1 Bryant A, Lawrie TA, Dowswell T et al Ivermectin for Prevention and Treatment of COVID-19 Infection. A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021 Jun 17. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34145166 https://journals.lww.com/americantherapeutics/Abstract/9000/Ivermectin_for_Prevention_and_Treatment_of.98040.aspx
    Hill A, Garratt A, Levi J et al Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Open Forum Infectious Diseases. 2021. July 6 https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab358/6316214
  201. The Korea Advanced Institute of Science and Technology (KAIST) Repurposed drugs present new strategy for treating COVID-19 MedicalXpress July 8, 2021 https://medicalxpress.com/news/2021-07-repurposed-drugs-strategy-covid-.html
    Jang WD et al Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc Natl Acad Sci. USA. 2021 Jul 27;118(30):e2024302118 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34234012 Free article https://www.pnas.org/content/118/30/e2024302118.long
  202. 202.0 202.1 Hinks TSC, Cureton L, Knight R et al Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir Med. 2021 Jul 9:S2213-2600(21)00263-0 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34252378 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00263-0/fulltext
    Oldenburg CE, Pinsky BA, Brogdon J et al. Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: A randomized clinical trial. JAMA 2021 Aug 10; 326:490. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34269813 PMCID: PMC8285753 (available on 2022-01-16) https://jamanetwork.com/journals/jama/fullarticle/2782166
    PRINCIPLE Trial Collaborative Group. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial. Lancet 2021 Mar 20; 397:1063. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33676597 PMCID: PMC7972318 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00461-X/fulltext
  203. 203.0 203.1 Ohl ME, Miller DR, Lund BC et al Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19. JAMA Netw Open. 2021;4(7):e2114741 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34264329 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781959
  204. 204.0 204.1 Abizanda P, Calbo Mayo JM, Mas Romero M et al Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia. J Am Getiatr Soc 2021. July 8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34235720 https://agsjournals.onlinelibrary.wiley.com/doi/full/10.1111/jgs.17357
  205. 205.0 205.1 The ATTACC, ACTIV-4a, and REMAP-CAP Investigators Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021. Aug 4 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34351722 https://www.nejm.org/doi/full/10.1056/NEJMoa2105911
  206. 206.0 206.1 Barratt-Due A et al. Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: A randomized trial. Ann Intern Med 2021 Jul 13; PMID: https://www.ncbi.nlm.nih.gov/pubmed/34251903 PMCID: PMC8279143 Free PMC article https://www.acpjournals.org/doi/10.7326/M21-0653
  207. 207.0 207.1 Sax P Could This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19? NEJM Journal Watch. HIV and ID Observations. August 12, 2021 https://blogs.jwatch.org/hiv-id-observations/index.php/could-this-be-our-first-effective-inexpensive-widely-available-outpatient-treatment-for-covid-19/2021/08/12/
  208. 208.0 208.1 Brooks M CPAP Better Than HFNO and Conventional Oxygen for COVID-19 Acute Respiratory Failure. Medscape August 11, 2021 https://www.medscape.com/viewarticle/956322
    Perkins GD, Ji C, Connolly BA et al An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19. medRxiv 2021 Aug 4 https://www.medrxiv.org/content/10.1101/2021.08.02.21261379v1
  209. 209.0 209.1 Strauss R, Jawhari N, Attaway AH Intranasal Corticosteroids are Associated with Better Outcomes in Coronavirus Disease 2019 (COVID-19). The Journal of Allergy and Clinical Immunology: In Practice. 2021. August 23. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34438103 PMCID: PMC8381621 Free PMC article https://www.sciencedirect.com/science/article/pii/S2213219821009065
  210. 210.0 210.1 The ATTACC, ACTIV-4a, and REMAP-CAP Investigators Lawler PR et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med 2021 Aug 26; 385:790. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34351721 PMCID: PMC8362594 Free PMC article https://www.nejm.org/doi/10.1056/NEJMoa2105911
    The ATTACC, ACTIV-4a, and REMAP-CAP Investigators Goligher EC et al. Therapeutic anticoagulation with heparin in critically ill patients with COVID-19. N Engl J Med 2021 Aug 26; 385:777. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34351722 PMCID: PMC8362592 Free PMC article https://www.nejm.org/doi/10.1056/NEJMoa2103417
    Ten Cate H. Surviving COVID-19 with heparin? N Engl J Med 2021 Aug 26; 385:845. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34347948 PMCID: PMC8362589 Free PMC article https://www.nejm.org/doi/10.1056/NEJMe2111151
  211. 211.0 211.1 211.2 Pickens CO, Gao CA, Cuttica MJ et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am J Respir Crit Care Med 2021 Aug 19; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34409924 https://www.atsjournals.org/doi/10.1164/rccm.202106-1354OC
  212. 212.0 212.1 212.2 212.3 Marconi VC, Ramanan AV, de Bono S et al. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): A randomised, double-blind, parallel-group, placebo- controlled phase 3 trial. Lancet Respir Med 2021 Sep 1; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/34480861 PMCID: PMC8409066 Free PMC article https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00331-3/fulltext
    Walker M JAK Inhibitor Shows Mortality Benefit in Severe COVID. U.K.'s RECOVERY trial finds baricitinib cut risk of death when added to usual care. MedPage Today March 4, 2022 https://www.medpagetoday.com/infectiousdisease/covid19/97493
  213. 213.0 213.1 Spyropoulos AC, Goldin M, Giannis D et al Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19. The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. Published online October 7, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34617959 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785004
  214. 214.0 214.1 Connors JM, Brooks MM, Sciurba FC et al Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19. The ACTIV-4B Randomized Clinical Trial. JAMA. Published online October 11, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34633405 https://jamanetwork.com/journals/jama/fullarticle/2785218
  215. 215.0 215.1 The COVID STEROID 2 Trial Group Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia. The COVID STEROID 2 Randomized Trial. JAMA. Published online October 21, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34673895 https://jamanetwork.com/journals/jama/fullarticle/2785529
    Webb SA, Higgins AM, McArthur CJ Glucocorticoid Dose in COVID-19. Lessons for Clinical Trials During a Pandemic. JAMA. Published online October 21, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34673891 https://jamanetwork.com/journals/jama/fullarticle/2785531
  216. 216.0 216.1 Sholzberg M, Tang GH, Rahhal H et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ 2021 Oct 14; 375:n2400 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34649864 PMCID: PMC8515466 Free PMC article https://www.bmj.com/content/375/bmj.n2400
  217. 217.0 217.1 Oskotsky T, Maric I, Tang A et al Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants. JAMA Netw Open. 2021;4(11):e2133090. Nov 15 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34779847 PMCID: PMC8593759 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786136
  218. 218.0 218.1 Pfizer Press Release. Nov 5, 2021 Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study. https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate
    McNamara D FDA Authorizes Pfizer Antiviral Pill for COVID-19. Medscape. December 22, 2021 https://www.medscape.com/viewarticle/965398
  219. 219.0 219.1 McNamara D FDA Okays Emergency Use of Molnupiravir Pill for COVID-19. Medscape. December 23, 2021 https://www.medscape.com/viewarticle/965484
  220. 220.0 220.1 Reuters Staff CDC Cuts Isolation Time for COVID-Affected Americans to 5 Days. Medscape. December 27, 2021 https://www.medscape.com/viewarticle/965621
    American Medical Association (AMA) CDC shortens isolation period for people with asymptomatic cases of COVID-19 to five days. AMA Morning Rounds. December 28, 2021
  221. Ospina-Tascon GA, Calderon-Tapia LE, Garcia AF et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: A randomized clinical trial. JAMA 2021 Dec 7; 326:2161. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34874419 https://jamanetwork.com/journals/jama/fullarticle/2786830
  222. 222.0 222.1 Diaz R, Orlandini A, Castellana N et al Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19A Randomized Clinical Trial. JAMA Netw Open. 2021;4(12):e2141328 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34964849 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787585
  223. 223.0 223.1 Frellick M Remdesivir Sharply Cuts COVID Hospitalization Risk, Gilead Says. Medscape. September 22, 2021 https://www.medscape.com/viewarticle/959284
    Gottlieb RL, Vaca CE, Paredes R et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med 2021 Dec 22; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34937145 https://www.nejm.org/doi/10.1056/NEJMoa2116846
  224. 224.0 224.1 Berger JS, Kornblith LZ, Gong MN et al Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non- Critically Ill Hospitalized Patients With COVID-19. A Randomized Clinical Trial. JAMA. 2022;327(3):227-236 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35040887 https://jamanetwork.com/journals/jama/fullarticle/2788141
  225. 225.0 225.1 Perkins GD, Ji C, Connolly BA et al Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19. The RECOVERY-RS Randomized Clinical Trial. JAMA. 2022;327(6):546-558 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35072713 PMCID: PMC8787685 (available on 2022-07-24) https://jamanetwork.com/journals/jama/fullarticle/2788505
    Zampieri FG, Ferreira FC Defining Optimal Respiratory Support for Patients With COVID-19. JAMA. 2022;327(6):531-533. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35072711 https://jamanetwork.com/journals/jama/fullarticle/2788506
  226. 226.0 226.1 Deng JZ, Chan J, Potter A et al. The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States. Ann Surg 2022 Feb; 275:242 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34793348 PMCID: PMC8745943 Free PMC article https://journals.lww.com/annalsofsurgery/Fulltext/2022/02000/The_Risk_of_Postoperative_Complications_After.7.aspx
  227. 227.0 227.1 REMAP-CAP Writing Committee for the REMAP-CAP Investigators Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19. JAMA. Published online March 22, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35315874 https://jamanetwork.com/journals/jama/fullarticle/2790488
    Connors JM, Ridker PM Thromboinflammation and Antithrombotics in COVID-19. Accumulating Evidence and Current Status. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35315488 JAMA. Published online March 22, 2022 https://jamanetwork.com/journals/jama/fullarticle/2790489
  228. 228.0 228.1 Andrews L et al. Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID-19 patients. J Hosp Med 2022 Feb 14; 17:169. Not indexed in PubMed https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.12789
  229. 229.0 229.1 Fralick M et al. Prone positioning of patients with moderate hypoxaemia due to covid-19: Multicentre pragmatic randomised trial (COVID-PRONE). BMJ 2022 Mar 23; 376:e068585 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35321918 PMCID: PMC8941343 Free PMC article https://www.bmj.com/content/376/bmj-2021-068585
  230. 230.0 230.1 Johnson SA et al Patient-directed Prone Positioning in Awake Patients with COVID-19 Requiring Hospitalization (PAPR). Ann Am Thorac Soc. 2021 Aug;18(8):1424-1426 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33596394 PMCID: PMC8513661 Free PMC article https://www.atsjournals.org/doi/10.1513/AnnalsATS.202011-1466RL
  231. 231.0 231.1 231.2 Lee KC et al. Pulse oximetry for monitoring patients with Covid-19 at home - A pragmatic, randomized trial. N Engl J Med 2022 Apr 6; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/35385625 PMCID: PMC9006781 Free PMC article https://www.nejm.org/doi/10.1056/NEJMc2201541
  232. 232.0 232.1 Alhazzani W, Parhar KKs, Weatherald J et al Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure. A Randomized Clinical Trial. JAMA. Published online May 15, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35569448 https://jamanetwork.com/journals/jama/fullarticle/2792506
  233. 233.0 233.1 233.2 Reuters Staff Bristol Myers, J&J Drugs Reduce COVID Death Rates in NIH Study. Medscape. June 3, 2022 https://www.medscape.com/viewarticle/974953
  234. 234.0 234.1 234.2 Bouadma L et al. High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: The COVIDICUS randomized clinical trial. JAMA Intern Med 2022 Jul 5; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35788622 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2794040
  235. 235.0 235.1 Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  236. 236.0 236.1 Bramante CT et al. Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19. N Engl J Med 2022 Aug 18; 387:599. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36070710 https://www.nejm.org/doi/10.1056/NEJMoa2201662
    Abdool Karim SS, Devnarain N. Time to stop using ineffective Covid-19 drugs. N Engl J Med 2022 Aug 18; 387:654. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36070715 https://www.nejm.org/doi/10.1056/NEJMe2209017
  237. 237.0 237.1 RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet 2022 Jul 30; 400:359 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35908569 PMCID: PMC9333998 Free PMC article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01109-6/fulltext
  238. 238.0 238.1 Baxter AL, Schwartz KR, Schwartz R et al Rapid initiation of nasal saline irrigation to reduce severity in high-risk COVID+ outpatients. Ear Nose Throat J. 2022 Aug 25:1455613221123737 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36007135 Free article. https://journals.sagepub.com/doi/10.1177/01455613221123737
  239. 239.0 239.1 Frat J-P et al. Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: The SOHO-COVID randomized clinical trial. JAMA 2022 Sep 27; 328:1212. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36166027 PMCID: PMC9516287 (available on 2023-03-27) https://jamanetwork.com/journals/jama/fullarticle/2796693
  240. 240.0 240.1 Bronze MS. Rapid Review Quiz: COVID-19 Updates. Medscape. Sep 28, 2022. https://reference.medscape.com/viewarticle/980879
  241. 241.0 241.1 Slomski A Vitamin D Supplements Don't Reduce COVID-19 Risk. JAMA. 2022;328(16):1581. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36282259 https://jamanetwork.com/journals/jama/fullarticle/2797574
  242. 242.0 242.1 Bassett M FDA Authorizes IL-1 Drug for Hospitalized COVID Patients. Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure. MedPage Today November 9, 2022 https://www.medpagetoday.com/infectiousdisease/covid19/101662
  243. 243.0 243.1 Ellis R The Right Indoor Relative Humidity Could Ward Off COVID. Medscape. Nov 21, 2022 https://www.medscape.com/viewarticle/984415
  244. 244.0 244.1 Ben Abdallah S et al. Twice-daily oral zinc in the treatment of patients with coronavirus disease 2019: A randomized double-blind controlled trial. Clin Infect Dis 2022 Nov 4; ciac807; [e-pub]. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac807/6795268
  245. 245.0 245.1 Cafardi J, Miller C, Terebelo H et al Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19. A Phase 2 Randomized Clinical Trial. JAMA Netw Open. 2022;5(12):e2242918. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36469321 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799198
  246. 246.0 246.1 Brevini T, Maes M, Webb GJ et al FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature 2022. Dec 5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36470304 https://www.nature.com/articles/s41586-022-05594-0
  247. 247.0 247.1 247.2 Crist C Which Treatments Improve Long-term Outcomes of Critical COVID Illness? Medscape. Jan 11, 2023 https://www.medscape.com/viewarticle/986848
    Writing Committee for the REMAP-CAP Investigators Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. JAMA. Published online December 16, 2022. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36525245 https://jamanetwork.com/journals/jama/fullarticle/2799870
    Barnett ML, Sax PE Long-term Follow-up After Critical COVID-19REMAP-CAP Revisited JAMA. Published online December 16, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36525259 https://jamanetwork.com/journals/jama/fullarticle/2799872
  248. 248.0 248.1 Dryden-Peterson S, Kim A, Kim AY et al Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System. A Population-Based Cohort Study. Ann Intern Med. 2022. Dec 13 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36508742 PMCID: PMC9753458 Free PMC article https://www.acpjournals.org/doi/10.7326/M22-2141
  249. 249.0 249.1 O'Mary L COVID-19 Monoclonal Antibody Treatments No Longer Effective. Medscape. Dec 5, 2022 https://www.medscape.com/viewarticle/985001
  250. 250.0 250.1 Fretheim A, Elgersma IH, Helleve A et al Effect of Wearing Glasses on Risk of Infection With SARS-CoV-2 in the Community. A Randomized Clinical Trial. JAMA Netw Open. 2022;5(12):e2244495 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36454571 PMCID: PMC9716386 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799115
  251. 251.0 251.1 251.2 Nolley EP, Sahetya SK, Hochberg CH et al Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies. JAMA Netw Open. 2023;6(1):e2250401. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36626168 PMCID: PMC9856712 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800158
  252. 252.0 252.1 Reis G, Moreira Silva EAS, Medeiros Silva DC et al Early Treatment with Pegylated Interferon Lambda for Covid-19. N Engl J Med 2023; 388:518-528. Feb 9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36780676 https://www.nejm.org/doi/full/10.1056/NEJMoa2209760
  253. 253.0 253.1 Fanlo P, del Carmelo Gracia-Tello B, Fonseca Aizpuru E et al Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19. A Randomized Phase 2/3 Clinical Trial. JAMA Netw Open. 2023;6(4):e237243. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2803480
  254. 254.0 254.1 Labbe V et al. Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: The ANTICOVID randomized clinical trial. JAMA Intern Med 2023 Mar 22; e230456. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36946232 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2802821
  255. 255.0 255.1 Writing Committee for the REMAP-CAP Investigators Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19. A Randomized Clinical Trial. JAMA. 2023;329(14):1183-1196. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37039790 https://jamanetwork.com/journals/jama/fullarticle/2803515
  256. 256.0 256.1 Stone GW et al. Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19. J Am Coll Cardiol 2023 May; 81:1747. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36889611 PMCID: PMC9987252 Free PMC article https://www.sciencedirect.com/science/article/pii/S0735109723045278
  257. 257.0 257.1 Wang TY et al. Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization. Ann Intern Med 2023 Apr; 176:515. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36940444 PMCID: PMC10064277 Free PMC article https://www.acpjournals.org/doi/10.7326/M22-3350
  258. 258.0 258.1 258.2 258.3 258.4 O'Halloran JA, Ko ER, Anstrom KJ et al Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia. A Randomized Clinical Trial. JAMA. 2023;330(4):328-339. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37428480 PMCID: PMC10334296 (available on 2024-01-10) https://jamanetwork.com/journals/jama/fullarticle/2807333
  259. 259.0 259.1 259.2 259.3 Lin DY, Fadel FA, Huang S et al Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections. JAMA Netw Open. 2023;6(9):e2335077. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37733342 PMCID: PMC10514733 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809779
  260. National Institutes of Health (NIH) https://www.covid19treatmentguidelines.nih.gov COVID-19 Treatment Guidelines. Last Updated: April 21, 2021 What's New in the Guidelines? https://www.covid19treatmentguidelines.nih.gov/whats-new/
  261. IDSA Guidelines https://www.idsociety.org.practice-guideline/covid-19-guideline-treatment-and-management
  262. Harris E Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS. JAMA. Published online November 8, 2023. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37938859 https://jamanetwork.com/journals/jama/fullarticle/2811885
  263. 263.0 263.1 Lin II RG Shorter Covid isolation - with a caveat. Mask up before going out when symtoms improve. loosened state guidelines say, Los Angeles Times. Jan 29, 2024
    Associated Press CDC Shortens COVID Isolation Recs. People testing positive for COVID no longer need to stay in isolation for 5 days. MedPage Today. March 1, 2024 https://www.medpagetoday.com/infectiousdisease/covid19/108981
  264. 264.0 264.1 Nielsen FM et al. Lower vs higher oxygenation target and days alive without life support in COVID-19: The HOT-COVID randomized clinical trial. JAMA 2024 Mar 19; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/38501214 PMCID: PMC10951852 (available on 2024-09-19) https://jamanetwork.com/journals/jama/fullarticle/2816676
  265. 265.0 265.1 Bramante CT, Beckman KB, Mehta T et al Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019. Clin Infect Dis. 2024 May 1:ciae159. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38690892 https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciae159/7660393
  266. 266.0 266.1 Faust J Paxlovid Trial Flops for COVID Pneumonia Small study found no decrease in mortality among inpatients in three countries MedPage Today June 6, 2024 https://www.medpagetoday.com/opinion/faustfiles/110516
    RECOVERY Collaborative Group Molnupiravir or nirmatrelvir-ritonavir versus usual3 care in patients admitted to hospital with COVID-194 (RECOVERY): a randomised, controlled, open-label,5 platform trial. medRxiv preprint. May 24, 2024 https://www.medrxiv.org/content/10.1101/2024.05.23.24307731v1.full.pdf

Patient information

SARS CoV2 management patient information